• Avricore is a leader in the health diagnostics space offering the most sophisticated and complete solution for pharmacy today
• The company is also leading a charge aimed at saving lives and money spent on health care
• Avricore partnered with Abbott Diagnostics becoming the first third-party technology company to hold distribution agreements with the manufacturer
• Avricore is currently entering a period of epic growth

Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF), a health diagnostics technology innovator, is a leader in the point-of-care (“POC”) diagnostics space and a company of several firsts. Through its flagship platform and eponymous wholly owned subsidiary, HealthTab(TM), Avricore has provided a proactive approach in the fight against diseases such as prediabetes, diabetes, SARS-CoV-2 (COVID-19), Influenza A and B, strep, and RSV (https://ibn.fm/DPsLu). Speaking during an interview with Stuart Smith as part of a recent Bell2Bell Podcast episode (https://ibn.fm/61OLh), AVCR CEO Hector Bremner summed up the company’s unique diagnostics and cloud-based technology by saying, “We are really excited to be leaders in the field. There’s nobody quite like us. There are people that do parts of what we do, but we have brought the most sophisticated and most complete solution for pharmacy today.” Better known as HealthTab, the solution is a fully automated, turnkey POC testing system that combines high-quality analyzers from manufacturers such as Abbott Diagnostics and Abaxis Global Diagnostics with a cloud-based solution, creating a network that benefits pharmacies and patients alike. For patients, the HealthTab system, through the analyzers, tests multiple key biomarkers associated with chronic and infectious diseases and subsequently generates lab-accurate, real-time results that patients can view via the system’s consumer-facing interface. For pharmacies, Bremner noted, Avricore provides an additional revenue-generating opportunity in the form of cognitive pharmacy services. In its vanguard role, Avricore is leading a charge that involves leveraging early detection and screening to save lives as well as the amount of money spent in health care. With early diagnosis having been proven as instrumental in reducing mortality and cardiovascular morbidity resulting from Type 2 diabetes (https://ibn.fm/7Htz0), as well as death caused by COVID-19 (https://ibn.fm/982Ml), HealthTab is indeed a boon. “I’ve always really believed that we need a true health care system [in Canada] that values early detection and screening if we really want to make sure that we’re not only saving lives but saving health care dollars in the future. We’re really passionate about leading this charge,” continued Bremner. Avricore’s leadoff stature also came into focus when it partnered with Abbott Diagnostics as part of a distribution agreement. Bremner, who described the partnership as groundbreaking, noted that Abbott does not ordinarily do distribution agreements for their technology with third-party technology companies like AVCR. “Normally, to distribute Abbott technologies at this level, you have to be a fairly large distributor of health care technologies to begin with. We were extremely fortunate to pioneer this agreement and really break ground to see what was possible as a value-added reseller to bring our technology in combination with theirs,” observed Bremner. Bremner noted that the partnership accelerated Avricore’s growth, further pointing out that the company is ideally poised for a great finish to the current year and continued growth through 2023, having repaid its debts and raised about $4.5 million this year. Avricore is committed to becoming the world’s largest health diagnostics company. With a primary focus on developing a network of POC analyzers that utilize its HealthTab software in community pharmacy, the company is staking a claim as a leader in the space. For more information, visit the company’s website at www.AvricoreHealth.com. NOTE TO INVESTORS: The latest news and updates relating to AVCRF are available in the company’s newsroom at https://ibn.fm/AVCRF

• Date: Nov. 4-5, 2021
• Venue: Amalie Arena, Tampa
• Agenda: Two days of presentations on the state of the fintech industry and its potential within the state of Florida as well as beyond its borders
• Tickets and Registration Info: https://www.eventbrite.com/e/florida-bitcoin-and-blockchain-summit-tickets-168286175481

An ongoing business migration to southern Florida’s international hub for commerce and travel is also sweeping in tech companies, and next month’s Florida Bitcoin and Blockchain Summit has been designed to harness that innovative market energy with a two-day in-person gathering that delivers a “clear and unique strategy on making Florida the leader in blockchain and financial technology” (https://ibn.fm/hCjwI). The Nov. 4 and 5 conference will take place at Tampa’s Amalie Arena, home of the current back-to-back NHL Stanley Cup Championship team the Tampa Bay Lightning. It will be organizer Chris Krimitsos’ second in-person event of the year in response to high demand for a timely gathering cognizant of the ongoing world pandemic conditions. Krimitsos is the innovator behind Florida’s internationally popular Podfest conference series. The first Bitcoin and Blockchain Summit he launched this summer in Orlando with entrepreneur Gabe Higgins introduced their aim to bring together stakeholders, businesses, and political leaders from across Florida as well as from outside the state to forge a continued growth strategy for the industry. “There is a lot of nuances to how blockchain is being used, but that’s the problem — we need to meet one another and know what everyone is doing, so we can have a cross-flow of ideas,” Krimitsos told business journal Tampa Bay Inno in June (https://ibn.fm/jHRQd). “You’ve got Miami, which the new financial capital of the country. And Tampa, Orlando, Jacksonville and other cities now have a huge opportunity to be the new Silicon Valley of blockchain if we play our cards right.” The journal noted that the metropolitan region has already attracted a number of blockchain and crypto power generators, including Celsius crypto co-founder Nuke Goldstein, Tampa-based blockchain company Pocket Network and blockchain-focused BlockSpaces founded by HIggins. The Tampa summit teams Krimitsos and Higgins with other Cutting Edge Events entrepreneurs to offer presentations in three tracks for beginners, stakeholders and advocates, bringing together both novices and experts to work in fostering growth within the blockchain and cryptocurrency sector. Tampa Mayor Jane Castor and more than two dozen companies and educators will be among the presenters. An associated Reach developers workshop on Nov. 5 at the Amalie Arena will provide the tools for developers to build blockchain applications in a matter of hours or days instead of weeks or months (https://ibn.fm/cuKqJ). For further information on the November conference and to obtain tickets for the event, visit https://floridablockchainsummit.com.

• CSU report notes that some forms of artificial cannabis plant production might not be environmentally friendly
• HENC sees environmental sustainability and minimizing carbon footprint as synonymous with being good corporate citizens and running a profitable business
• Company’s proprietary aeroponic cultivation system, high-tech sun chambers have minimal environment impact

In an atmosphere focused on sustainability and the environment, many consumers are taking a closer look at how things are made and the impact those things have on the world. Cannabis cultivation has not gone unnoticed, with a recent Colorado State University (“CSU”) report shining a spotlight on the sector (https://ibn.fm/jK31I). Committed to a strategic grow plan that produces high-efficiency, low-carbon-footprint crops, cannabis company Hero Technologies (OTC: HENC) pays close attention to these reports to ensure sustainability. “Generally, consumers want to better understand a product’s impact on the environment, often concerned with greenhouse gas emissions,” stated the CSU article, titled “Marijuana’s High Environmental Burden.” The article noted that marijuana, now legally available as a recreational drug, is often overlooked as far as its environmental impact. “Well, here at Colorado State University, we investigated the environmental impact of traditional marijuana cultivation practices. The results might surprise you. . . . “Since recreational legalization, the marijuana industry has seen exponential growth,” the article continued. “In Colorado alone, more than one million pounds of marijuana are grown annually. However, more than 80% of that one million pounds is grown indoors. That’s right, plants being grown inside warehouse-like buildings without access to the sun. This requires energy-intense grow lights, fans to circulate air and strengthen stems, carbon dioxide gas to increase plant growth and sophisticated equipment to maintain a comfortable temperature and humidity.” The article noted that those were only a few of the environmental control systems required to grow marijuana plants indoors, with the majority of such systems relying on electricity or natural gas. “Considering this energy is primarily made through combustion of fossil fuels, you may be starting to connect the dots here, realizing that this form of artificial plant production might not be so environmentally friendly,” the article observed. Hero Technologies cultivation systems, on the other hand, uses a proprietary aeroponic cultivation system and high-tech sun chambers designed to produce high plant density and yields but with minimal environment impact. “We see environmental sustainability and minimizing our carbon footprint as synonymous with being good corporate citizens and running a profitable business,” said Hero Technologies CEO Gina Serkasevich. “Sustainable cannabis production has mutually reinforcing drivers: increasing productivity, conserving energy and other resources, reducing environmental waste, and maximizing profitability.” The system, designed by HENC subsidiary BlackBox Systems and Technologies LLC, produces ideal growing conditions with highly efficient use of materials, resulting in greater photosynthesis, high plant flowers, and optimal harvest yields while also decreasing the carbon footprint per pound of product produced (https://ibn.fm/zynzw). BlackBox has also partnered with industry leader Ceres Greenhouse Solutions to build innovative, energy-efficient cannabis sun chambers, designed to maximize sunlight to reduce energy use and trap supplemental CO2 to avoid emissions into the atmosphere. The sun chambers, which feature sensors and controllers to regulate the environment and avoid energy waste, also provide renewable, local geothermal energy for unusually efficient heating, cooling and dehumidification. “Traditional HVAC and lighting systems can represent close to half of a typical cannabis grower’s operating costs,” said Serkasevich. “But we anticipate that our aeroponic growing system and super-efficient sun chambers could reduce those operating costs by one-third or more. . . . In addition, we expect our cannabis cultivation technologies to produce optimal plant density and crop cycles for the lowest possible cost-per-yield, which is the biggest contributor to sustainability, efficiency, and positive environmental impact.” Hero Technologies Inc. is a cannabis company working toward a vertically integrated business model. The company’s strategic business plan includes cannabis genetic engineering, space for both medical and recreational cannabis cultivation, production licenses, distribution licenses, consumer packaging, and retail and dispensary operations that make the company a multistate operator. For more information, visit the company’s website at www.HeroTechnologiesInc.com. NOTE TO INVESTORS: The latest news and updates relating to HENC are available in the company’s newsroom at https://ibn.fm/HENC

• Oral drug delivery innovator Lexaria Bioscience is focused on providing alternatives to smoked or inhaled tobacco and cannabis products to help consumers reduce the threat to their lungs
• Lexaria’s patented technology — DehydraTECH(TM) — is a solution that processes active pharmaceutical ingredients into a powder or liquid form that can then be ingested with less harm than inhalation, while providing rapidity similar to inhalation substances
• DehydraTECH has previously shown the ability to move CBD into test subjects’ bloodstreams up to 20-fold higher than standard generic formulations
• New testing shows that DehydraTECH can similarly deliver THC to test subjects’ bloodstreams at rates faster and well above those of standard formulations for oral THC use

A leader in innovative drug delivery platforms, Lexaria Bioscience (NASDAQ: LEXX) aims to reduce or eliminate the use of inhaled and addictive products by focusing on ways to deliver nicotine into smokers’ bloodstreams at levels comparable to the nerve-settling relief they get from cigarettes and other tobacco products, providing them an alternative to purchasing store brands likely to harm their lungs. The company has enhanced its pursuit by testing its solution — its patented DehydraTECH technology — as an alternative to smoked or vaped cannabis products as well, and is reporting continued breakthroughs in DehydraTECH’s performance against the industry standard medium-chain triglyceride-based control formulation (coconut oil). “The cannabis industry continues to use outdated formulations and processes that ignore the needs of modern THC users,” Lexaria CEO Chris Bunka stated in an Oct. 13 news release regarding DehydraTECH-delivered tetrahydrocannabinol effectiveness (https://ibn.fm/Gs0Ni). “THC users today include medicinal and pharmaceutical users, all of whom need technology that doesn’t rely on harmful delivery methods such as smoking but still provides rapid onset and high bioavailability which common oral formats do not offer. Our study findings demonstrated rapid delivery, increased overall THC delivery, and higher brain tissue delivery; all of which is consistent with the wants and needs of THC customers.” Specifically, the THC absorption study showed that the standard coconut oil THC formulation required 45 minutes to reach the same levels that DehydraTECH-THC produced after 15 minutes.  In the meantime, the DehydraTECH-THC was continuing to achieve higher levels of bloodstream delivery up until about the three-hour mark — well past coconut oil THC’s peak — and didn’t fall back to levels equal to the coconut oil medium until about the six-hour mark. The testing also noted that in two samplings of subjects’ brain tissue, DehydraTECH-THC levels were effectively twice as high as the coconut oil controls, demonstrating the further potential of DehydraTECH’s technology. This builds on previous results showing DehydraTECH can deliver cannabidiol (“CBD”) into the bloodstream at a rate 2,178 percent higher than generic industry control formulations, with 1,737 percent more CBD being moved across the blood-brain barrier than with those generic formulations Lexaria’s testing is focused on medical applications of THC delivery. The Harvard Medical School’s publishing wing has noted that the most common use for medical cannabis in the United States is to control pain, particularly in response to select chronic conditions (https://ibn.fm/Hm8uy). Lexaria’s technology is also undergoing clinical and pre-clinical trials for potential use in treating hypertension, viral infections and other conditions currently targeted by CBD-based nutraceuticals and pharmaceutical drugs DehydraTECH processes active pharmaceutical ingredientsinto a powder or liquid form for oral delivery. Other testing has shown its ability to become rapidly bioavailable by bypassing first-pass-liver processing, while also avoiding alteration of the drug substance during its conversion in such a way that would reduce the drug’s effectiveness or create unexpected drug entities requiring further regulatory attention for approval (https://ibn.fm/1Ccyq). “The fact that (DehydraTECH) is fast means that smokers might not be frustrated waiting for their nicotine experience to begin, the way they have been with traditional nicotine products such as gums and lozenges,” Bunka said in a Forbes interview about the solution’s potential impact on the tobacco market (https://ibn.fm/Bk9lW). “My father also died from lung cancer …, so I am no fan.” For more information, visit the company’s website at www.LexariaBioscience.com. NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

• The growing cannabis industry is experiencing a rise in demand for experienced business executives to guide companies toward the top
• Flora Growth, which has achieved numerous milestones, is a testament to the importance of experienced leadership
• Established in 2019, Flora was the first all-outdoor cannabis cultivation company to list on NASDAQ and has the largest licensed cultivation footprint in Colombia
• The company also boasts the lowest production cost in the world of $0.06 per gram of dried flower
• Flora’s adherence to strict industry standards and prudent management of its finances positions it to become a global leader in the cannabis space

As the cannabis industry has continued to grow, so too has the demand for experienced business executives needed to steer cannabis companies to the top. Such executives, especially those brought in from industries experiencing similar regulations as the cannabis space, are particularly helpful as companies scale. According to a recent Benzinga article, leadership from outside industries provides the much-needed boardroom experience to bring a startup to a grander stage (https://ibn.fm/MW0XS). For Flora Growth (NASDAQ: FLGC), a global cannabis company leveraging all-natural, low-cost cultivation practices to supply cannabis flower and derivatives to its diverse divisions, Benzinga’s observations accurately narrate its story. Flora’s management team comprises disciplined operators, brand builders, and category disruptors with a track record of building direct-to-consumer brands and a loyal, engaged community. Collectively, the professionals share decades of industry-leading experience building consumer packaged goods (“CPG”) brands and managing global e-commerce, retail, distribution, and pharmaceutical research (https://ibn.fm/kahAB). And as FLGC President and CEO Luis Merchan notes, this makes for the perfect impetus for growth in the cannabis industry. “The industry is going through a period of transformation where operations, supply chain management, project management, and financial discipline are becoming imperatives in the skill set of executives that lead cannabis companies,” said Luis Merchan. A proven leader with more than a decade of experience in enterprise sales, management, corporate strategy, merchandising and expense management, and customer experience, Merchan previously served as the Vice President of Workforce Strategy and Operations at Macy’s Inc. (NYSE: M), an Ohio-headquartered omnichannel retailer, where he managed the company’s P&L expense line for its 540 stores. Prior to this role, Merchan held various executive-level positions at Macy’s and managerial roles at Target (NYSE: TGT). Merchan is part of a diverse group of business professionals focused on the responsible growth of the company and who make up the board of directors, advisors, and management team. Through their guidance, Flora Growth, which was established in 2019, has achieved numerous milestones. “We are the first all-outdoor cannabis cultivation company to list on NASDAQ. We accomplished that on May 11th,” explained Merchan during the Benzinga Cannabis Hour Live Interview (https://ibn.fm/GwYjF). “We have tremendous strategies. One of them is the cultivation of wholesale cannabis at the lowest production cost in the world. We have been able to achieve a cost structure of about $0.06 per gram of dried flower.” Merchan also noted that the second strategy entails creating a brand portfolio of products that resonates with global consumers. With New Frontier Data projecting that the global legal cannabis market will grow from $23.7 billion in 2020 to $51 billion in 2025, representing a 16.6% CAGR (https://ibn.fm/AGaGh), Flora Growth is ideally poised to become a global leader in the space thanks to several factors. The economics associated with the company’s production facilities in Colombia are very attractive and the management team said it produces cannabis for as low as $0.06 per gram. The management team has been executing a global growth strategy and is focused on capturing market share in several international jurisdictions in the near term, including the European Union (“EU”), Australia, Panama, and South Africa. Further, FLGC is committed to prudent management of its finances, positioning it for long-term growth while allowing it to maintain a positive cash balance over the long term (https://ibn.fm/wczH6). In its mission to build a connected, mindful collective of plant-based wellness and lifestyle brands that deliver the most compelling customer experiences in the world, one community at a time, Flora Growth is banking on the guidance from its exceptional leadership to deliver on its mandate and rise to greater heights. For more information, visit the company’s website at www.FloraGrowth.ca. NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://ibn.fm/FLGC

• Tryp announced its inclusion in the AdvisorShares Psychedelics ETF
• The company hopes that its participation will open it up to a more diverse shareholder base and broaden its life science exposure
• Tryp’s presentation at the KCSA Virtual Investor Conference will also be available for on-demand viewing over the next 90 days

Launched back in September 2021, the AdvisorShares Psychedelics Exchange-Traded Fund (“ETF”) has been actively trading, focusing on enterprises that have devoted a significant proportion of their assets to psychedelic drug development. Operating under the ticker symbol “PSIL” on the New York Stock Exchange (“NYSE”) Arca exchange, this fund has built a portfolio that includes over 25 different psychedelic companies. Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) is the latest addition to that group. Tryp is excited with its inclusion in the fund, particularly since it provides an opportunity to bring a more diverse shareholder base while also broadening life science exposure for the company (https://ibn.fm/8DMHm). Its operations and commitment to developing psilocybin-based compounds for ailments with high unmet medical needs line up with AdvisorShares ETF’s main objective and focus. Interested parties can now also access Tryp’s KCSA Psychedelics Virtual Investor Conference presentation. In partnership with KCSA Strategic Communications, Virtual Investor Conferences announced that this and other presentations from critical players within the psychedelics space are now available for on-demand viewing (https://ibn.fm/oVNWI). The two-day event, held on October 13-14, 2021, featured a live overview of Tryp’s activities while elaborating on how it is leading the next wave of psychedelic drug development beyond mental health, focusing on chronic pain and other indications (https://ibn.fm/DcNgu). These presentations will be available 24/7 over the next 90 days. Interested parties, analysts, investors, and advisors can also download shareholder materials from the company’s “virtual trade booth.” For those who wish to access the presentations, you can register or log in now at https://ibn.fm/ZQiNc For more information, visit the company’s website at www.TrypTherapeutics.com. NOTE TO INVESTORS: The latest news and updates relating to TRYPF are available in the company’s newsroom at https://ibn.fm/TRYPF

• Market analysts and investors are preparing for inflation to reach high levels as a result of COVID-19 pressures, although key financial policy managers expect inflation pressures to be temporary
• Analysts are also observing the 50th anniversary of the end of the gold standard in the United States with reports that offer mixed views on gold’s ability to hedge against inflation in the short term, but its proven success for long-term prospects
• Amid the uncertainty in preparing for the coming years’ economic trends, mineral property acquisition company StraightUp Resources is building asset classes such as gold in high-value regions
• The company has acquired options to four sites in the well-known greenstone belt surrounding Ontario’s Red Lake Mining District and in Nevada’s famed Bullfrog boom zone

Fifty years after President Richard Nixon ended the U.S. dollar’s convertibility into gold, financial analysts have been weighing in on the gold standard’s end and the results of using gold as a hedge against inflation during the years since (https://ibn.fm/TAT6w). In the wake of briefly devastating economic conditions resulting from the COVID-19 pandemic, many investors have been concerned about the prospect of ‘high’ inflation arising now from tight supply lines and massive government debt on a global scale, according to varied news reports including a recent Reuters overview (https://ibn.fm/j80xD). A quick Google search shows analysts are largely in agreement that gold and changes in the U.S. consumer price index (“CPI”) have not followed a linearly parallel path during the past five decades, suggesting that gold has not been the ultimate short-term fix for inflationary worries in the past. Still, as Reuters notes, “gold is a proven long-term hedge against inflation” and also “can help investors protect against potentially excessive asset price inflation and currency debasement.” Canada-based mineral exploration and mining property acquisition company StraightUp Resources (CSE: ST) is building for the future with a series of acquisitions in historically proven gold districts, starting with options for the RLX North, RLX South, and Belanger Red Lake gold properties in Ontario obtained last year (https://ibn.fm/5tt5u). StraightUp followed up on those acquisitions with the Ferdinand Gold Property this year, marking a linear extension eastward from the other Ontario properties, and then the acquisition of the West Cat Mine across the continent in the state of Nevada last month (https://ibn.fm/uWhWY). The Ontario properties are located in the Canadian province’s west-side Red Lake Mining District, which has shown a store of silver and copper assets in addition to its historic gold production. Among the four sites, Ferdinand stands out in the sense that a lack of access has largely prevented previous exploration on the property despite its position within a well-known greenstone belt that has attracted other mine operations nearby. There isn’t a single registered drill hole on the property despite its situation as an extension of the prolific Uchi Subprovince, one of the most metal endowed greenstone belts in the world by square kilometer, according to StraightUp (https://ibn.fm/Iddxs). The company has completed a high-resolution heli-borne magnetic survey (“MAG”) on the Ferdinand property and has now received a final report on the survey. Orix Geoscience will interpret the final report during the coming weeks. StraightUp has also completed MAG surveys on RLX North and RLX South, which at about 10,000 hectares (25,000 acres) are the company’s largest area of operation currently. Ground exploration has begun and StraightUp will use the MAG surveys to help pinpoint future drill programs, President and CEO Mark Brezer has indicated. The Nevada property is a 20.66-acre land package in a high-potential area that has drawn other explorers’ interest as well. “(Nevada is) the second-largest (silver) producer in the United States, after Alaska, and, in 2014, Nevada produced roughly 11 million troy ounces — more than half of which came as a byproduct from gold mining,” Brezer noted in the West Cat Mine announcement. “We are extremely excited to begin our expansion into new mining districts and continue to position ourselves among top-quality assets and companies.” In addition, StraightUp recently acquired the Bear Head Gold Property in western Ontario, comprising 31 mining claims totaling 1,944 hectares in the Meen-Dempster Greenstone Belt, which hosts the Golden Patricia former gold mine that produced 620,000 ounces of gold at an average grade of 15.2 g/t from 1988-1997. According to Brezer, this acquisition complements the Ferdinand Gold Property.  The Bear Head Gold Project lies proximal to the Bear Head Deformation Zone (“BHDZ”), a 1st order crustal scale regional fault system over 2km wide that extends over 400km from the Pickle Lake Gold Camp, northeast through Ontario and into Manitoba. For more information, visit the company’s website at www.StraightUpResources.com. NOTE TO INVESTORS: The latest news and updates relating to ST are available in the company’s newsroom at https://ibn.fm/STR

• Friendable has begun testing for social media campaigns and digital advertising for its Fan Pass Live Streaming artist platform using Facebook and other networks
• Company’s goal for the next 90 days and into the new year is to shift focus on testing, converting, and growing the platform’s artist and fan bases
• An upward trend in live streaming and the creator economy is expected to drive consumer spending to $17.2 billion annually by 2025

Focused on artist acquisition and genre diversity, mobile technology and marketing company Friendable (OTC: FDBL) recently began testing campaigns on Facebook and other networks for their Fan Pass platform. These digital advertising and social media campaigns were designed to attract artists across various musical genres. As initial results from testing are received, the company plans to extend its sights to other platforms like Google, YouTube, and TikTok (https://ibn.fm/D4TyF). Having recently concluded its initial 120-day plan, Friendable has entered the remaining 90 days of the year looking to extend its brand awareness and artist offering. The company plans to include genre-targeted individuals, including industry managers, venues, and music-related booking services. To this end, Friendable has been working with Lobeline Communications, which is handling all of the company’s public relations and accelerated social media coverage. “As we enter the final quarter of the year, we have our sights set on testing, converting, and growing our artist and fan bases. At the same time, we continue monetizing our service offering and fan subscriptions,” Friendable CEO Robert A. Rositano Jr. said in reference to moving into the new year. “From inception, the Fan Pass Livestream platform has seen our business model perform at a micro-level; now, it’s time to add some scale to our artist and fan subscribers, as well as testing additional fee-based service offerings that are truly needed and appreciated by the independent artist community.” The Fan Pass platform is artist and fan-oriented, with newly designed applications available for Android and iOS operating systems. The live streaming community built by Friendable through Fan Pass allows artists to generate revenue and fans to listen to the artists they love while discovering new ones through a musically oriented community of like-minded individuals. Artists have the opportunity to use Pro Services, a hand-selected assortment of resources available to artists (at a cost) to develop merchandising, logos, social media posts, and more. The online shop allows artists to purchase equipment and other items they may need for their performances. Fans sign up, paying a monthly fee, to gain access to their favorite artists, with the opportunity to purchase exclusive merchandise and tickets to exclusive VIP shows. According to Rositano, as results of the company’s campaigns unfold, Fan Pass will report on metrics, conversions, rankings, and revenues that have garnered enough traction to extrapolate results and push for scale as the campaign builds momentum or adjusts based on response rates. “We remain focused and confident about what we have seen to date – it’s all about relationships, scale, and continuing to iterate our technology as we grow,” he added. The Fan Pass platform’s remarkable growth and increase in popularity comes at a time when the entire live streaming market and creator economy are experiencing an upward trend. It is estimated that consumers will spend a total of $6.78 billion on social apps in 2021. This amount is expected to grow at a CAGR of 29%, resulting in an estimated $17.2 billion spent annually by 2025. The U.S. and Japan currently dominate this market, spending more than $1.5 billion on social apps during H1 2021 (https://ibn.fm/Qq8E4). Additionally, research indicates that 740 billion hours of consumer time was spent on social apps in Q2 2021. The total time spent on live streaming apps on Android phones alone is set to exceed half a trillion hours outside of China by the end of 2021. For more information, visit the company’s websites at www.Friendable.com or www.FanPassLive.com. NOTE TO INVESTORS: The latest news and updates relating to FDBL are available in the company’s newsroom at http://ibn.fm/FDBL

• A 2020 DSA study reports that interest in direct sales is highest among younger generations
• An impressive 77% of Americans are interested in the flexibility, income potential found in direct sales
• Earlier this year, SHRG announced The Happy Co., a unique company that offers a powerful direct-sales opportunity

Although direct sales has been around for centuries — a history of the industry notes that “as hunter-gatherers settled down to farm and build towns, the first direct sellers began to sell their wares across Europe, Africa and Asia” — the first real direct-selling company was established in the mid-1850s (https://ibn.fm/1Vw2J). Despite that long history, a 2020 Direct Selling Association (“DSA”) study reported that interest in direct sales is highest among younger generations (https://ibn.fm/MEMTP). Sharing Services Global (OTCQB: SHRG), a publicly traded company specializing in the direct-sales sector, is keeping this in mind as the company completes a rebranding campaign designed to appeal to those looking for entrepreneurial opportunities. According to the DSA report, an impressive 77% of Americans are interested in the flexibility and income potential found in direct sales; even more notable is the fact that Gen Zers (91%) and Millennials (88%) top the list of those interested. Younger generations are often more entrepreneurial minded, and direct sales offers wide-open possibilities to those involved, allowing them to choose for themselves the level of time, money and resources to invest. Another attractive piece of the direct-sales opportunity is the low required startup costs. DSA noted that when compared to other business opportunities, such as real estate, property rental, Uber or Lyft driving, and fast-food restaurants, direct sales startup costs are substantially lower. The average starter kit is $82.50, while costs to get into other businesses range from $500 to more than $1 million. Finally, DSA notes that U.S. consumers remain positive toward direct sales, with perceptions toward direct selling remaining at about 80% for the past decade. Consumers note that most appealing about direct sales is the opportunity to support small business and the personalized service that direct sellers provide. This is good news for SHRG, which earlier this year announced The Happy Co., a direct-sales opportunity that offers functional beverages, capsules, patches and creams exclusively formulated to elevate mood, boost energy, reduce stress, enhance sleep, increase muscles, minimize fat, tighten skin, and make users look, feel and perform like a younger person. The Happy Place products fall in the nootropics category, or nutraceutical formulations derived from food sources that provide health benefits above and beyond basic nutritional value. Sharing Services Global Corporation is dedicated to maximizing shareholder value through the acquisition and development of innovative companies, products and technologies. The Sharing Services combined platform leverages the capabilities and expertise of various companies that market and sell products direct to the consumer. Its primary division includes Elevacity U.S. LLC, the parent company of the Happy Co. and a sales and marketing company based on utilization of independent contractors as the sales force. For more information, visit the company’s websites at www.SHRGInc.com and www.TheHappyCo.com. NOTE TO INVESTORS: The latest news and updates relating to SHRG are available in the company’s newsroom at http://ibn.fm/SHRG

• Substances such as psilocybin, ketamine and LSD are edging into mainstream culture, setting the stage for a paradigm shift in modern medicine
• Cybin has filed an international patent application covering methods for the delivery of psychedelic medications by inhalation
• The company is pursuing the effectiveness of using inhalation as a delivery method for psychedelic medications

Earlier this month, a Time magazine article reported on the “new era” of psychedelic medicine (https://ibn.fm/bfC3u). On the leading edge of this collective breakthrough is Cybin (NEO: CYBN) (NYSE American: CYBN), a company focused on progressing psychedelic therapeutics, addressing the mental health crisis and transforming the treatment landscape. As part of its mission, the company has filed an international patent application related to delivery methods of psychedelic medications (https://ibn.fm/vaIVQ). “As a growing number of states and cities move to decriminalize drugs, and investors flock to an emerging market for psychedelic health care, substances like psilocybin, ketamine and LSD are edging into mainstream culture—and setting the stage for a paradigm shift in modern medicine,” stated the Time article.  “Within the next few years, we could see psychedelic therapies prescribed for refractory depression and post-traumatic stress disorder (‘PTSD’), or used in palliative care among those facing a life-limiting illness. . . . It’s no coincidence that psychedelics are entering the conversation at the moment we most sorely need new ideas in mental health care.” Committed to finding answers to the growing need for effective mental health care solutions, Cybin has filed an international patent application covering methods for the delivery of psychedelic medications by inhalation as well as devices for performing those methods. The application, which is governed by the Patent Cooperation Treaty (“PCT”), would give Cybin potential to obtain patent coverage in 153 countries. “The continued progression of our research programs guides our discovery of new molecules and differentiating treatment approaches,” said Cybin CEO Doug Drysdale. “Continued innovation, as demonstrated by our expanding IP portfolio, positions Cybin as a leading innovator in the development of putative psychedelic treatments for a variety of mental health conditions.” Based on its research and study, Cybin is pursuing the effectiveness of using inhalation as a delivery method for psychedelic medications. Traditional oral drug administration presents certain challenges that CYBN believes can be alleviated through inhalation of the psychedelic substance. Specifically, the company reports, it expects inhalation delivery to facilitate optimized psychedelic session timing compared to oral administration of the same compounds, lower doses of psychedelic therapeutics while preserving efficacy, and providing health care providers with more control during psychedelic sessions. The patent was filed in support of Cybin’s CYB004 preclinical development program. The patent would increase the company’s library of drug-delivery modalities focused on optimal delivery of psychedelics and strengthen Cybin’s growing IP portfolio. The filing also includes support for future research programs the company may undertake, including those exploring various ways to reduce or minimize negative side effects in psychedelic psychotherapy patients. The company may also look at ways to lower medication doses without impacting treatment efficacy while increasing the long-term efficacy of psychedelic sessions. Cybin is a leading biotechnology company focused on progressing psychedelic therapeutics by utilizing proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for psychiatric disorders. For more information, visit the company’s website at www.Cybin.com. NOTE TO INVESTORS: The latest news and updates relating to CYBN are available in the company’s newsroom at https://ibn.fm/CYBN